{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:18:13Z","timestamp":1784542693887,"version":"3.55.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62755-1","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T16:26:23Z","timestamp":1754756783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Design of Ig-like binders targeting \u03b1-synuclein fibril for mitigating its pathological activities"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuyi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houfang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-7795","authenticated-orcid":false,"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-6672","authenticated-orcid":false,"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-925X","authenticated-orcid":false,"given":"Zhizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2884-3101","authenticated-orcid":false,"given":"Wenqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-1539","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"62755_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"62755_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini, M. G. & Goedert, M. The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N.Y. Acad. Sci. 920, 16\u201327 (2000).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"62755_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","volume":"265","author":"H Braak","year":"1999","unstructured":"Braak, H., Sandmann-Keil, D., Gai, W. & Braak, E. Extensive axonal Lewy neurites in Parkinson\u2019s disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci. Lett. 265, 67\u201369 (1999).","journal-title":"Neurosci. Lett."},{"key":"62755_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat. Med. 14, 504\u2013506 (2008).","journal-title":"Nat. Med."},{"key":"62755_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molmed.2020.03.012","volume":"26","author":"N Uemura","year":"2020","unstructured":"Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M. & Trojanowski, J. Q. Cell-to-cell transmission of tau and \u03b1-synuclein. Trends Mol. Med. 26, 936\u2013952 (2020).","journal-title":"Trends Mol. Med."},{"key":"62755_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"62755_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo, J. L. & Lee, V. M. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med. 20, 130\u2013138 (2014).","journal-title":"Nat. Med."},{"key":"62755_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641.e7 (2019).","journal-title":"Neuron"},{"key":"62755_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med. 14, 501\u2013503 (2008).","journal-title":"Nat. Med."},{"key":"62755_CR10","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA 106, 13010\u201313015 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199\u2013212 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"62755_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557, 558\u2013563 (2018).","journal-title":"Nature"},{"key":"62755_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332\u20131340 (2018).","journal-title":"Nat. Neurosci."},{"key":"62755_CR14","doi-asserted-by":"crossref","unstructured":"Long, H. et al. Wild-type \u03b1-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding. Proc. Natl. Acad. Sci. USA 118, e2012435118 (2021).","DOI":"10.1073\/pnas.2012435118"},{"key":"62755_CR15","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122, 1437\u20131448 (1999).","journal-title":"Brain"},{"key":"62755_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","volume":"8","author":"D B\u00e9raud","year":"2013","unstructured":"B\u00e9raud, D. et al. Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein \u03b1-synuclein. J. Neuroimmune Pharm. 8, 94\u2013117 (2013).","journal-title":"J. Neuroimmune Pharm."},{"key":"62755_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang, W. et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J. 19, 533\u2013542 (2005).","journal-title":"FASEB J."},{"key":"62755_CR18","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich, H. et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 184, 5089\u20135106.e21 (2021).","journal-title":"Cell"},{"key":"62755_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.adp3645","volume":"387","author":"KM Wu","year":"2025","unstructured":"Wu, K. M. et al. Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson\u2019s disease. Science 387, 892\u2013900 (2025).","journal-title":"Science"},{"key":"62755_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49016-3","volume":"15","author":"X Mao","year":"2024","unstructured":"Mao, X. et al. Aplp1 interacts with Lag3 to facilitate transmission of pathologic \u03b1-synuclein. Nat. Commun. 15, 4663 (2024).","journal-title":"Nat. Commun."},{"key":"62755_CR21","doi-asserted-by":"crossref","unstructured":"Zhang, S. et al. Mechanistic basis for receptor-mediated pathological \u03b1-synuclein fibril cell-to-cell transmission in Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 118, e2011196118 (2021).","DOI":"10.1073\/pnas.2011196118"},{"key":"62755_CR22","unstructured":"Mao, X. et al. Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 353, aah3374 (2016)."},{"key":"62755_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.656426","volume":"15","author":"H Gu","year":"2021","unstructured":"Gu, H. et al. Lymphocyte activation gene 3 (Lag3) contributes to \u03b1-synucleinopathy in \u03b1-synuclein transgenic mice. Front. Cell Neurosci. 15, 656426 (2021).","journal-title":"Front. Cell Neurosci."},{"key":"62755_CR24","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1021\/jacs.2c10854","volume":"145","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Conformational dynamics of an \u03b1-synuclein fibril upon receptor binding revealed by insensitive nuclei enhanced by polarization transfer-based solid-state nuclear magnetic resonance and cryo-electron microscopy. J. Am. Chem. Soc. 145, 4473\u20134484 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"62755_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","volume":"17","author":"K Chen","year":"2022","unstructured":"Chen, K. et al. LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread. Mol. Neurodegener. 17, 57 (2022).","journal-title":"Mol. Neurodegener."},{"key":"62755_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13024-022-00582-4","volume":"17","author":"C Pan","year":"2022","unstructured":"Pan, C. & Peng, C. LRP1: a novel receptor for the transmission of pathological \u03b1-synuclein. Mol. Neurodegener. 17, 79 (2022).","journal-title":"Mol. Neurodegener."},{"key":"62755_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"YT Sui","year":"2014","unstructured":"Sui, Y. T., Bullock, K. M., Erickson, M. A., Zhang, J. & Banks, W. A. Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 62, 197\u2013202 (2014).","journal-title":"Peptides"},{"key":"62755_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","volume":"133","author":"N Dzamko","year":"2017","unstructured":"Dzamko, N. et al. Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 133, 303\u2013319 (2017).","journal-title":"Acta Neuropathol."},{"key":"62755_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09257-3","volume":"7","author":"J Gasparotto","year":"2017","unstructured":"Gasparotto, J. et al. Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation. Sci. Rep. 7, 8795 (2017).","journal-title":"Sci. Rep."},{"key":"62755_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neulet.2018.02.049","volume":"672","author":"X Jiang","year":"2018","unstructured":"Jiang, X., Wang, X., Tuo, M., Ma, J. & Xie, A. RAGE and its emerging role in the pathogenesis of Parkinson\u2019s disease. Neurosci. Lett. 672, 65\u201369 (2018).","journal-title":"Neurosci. Lett."},{"key":"62755_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111401","volume":"40","author":"H Long","year":"2022","unstructured":"Long, H. et al. Interaction of RAGE with \u03b1-synuclein fibrils mediates inflammatory response of microglia. Cell Rep. 40, 111401 (2022).","journal-title":"Cell Rep."},{"key":"62755_CR32","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","volume":"111","author":"F Garretti","year":"2023","unstructured":"Garretti, F. et al. Interaction of an \u03b1-synuclein epitope with HLA-DRB1(\u2217)15:01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease. Neuron 111, 3397\u20133413.e5 (2023).","journal-title":"Neuron"},{"key":"62755_CR33","doi-asserted-by":"crossref","unstructured":"Gao, Y. et al. CD4(+) T-cell senescence in neurodegenerative disease: pathogenesis and potential therapeutic targets. Cells 13, 749 (2024).","DOI":"10.3390\/cells13090749"},{"key":"62755_CR34","doi-asserted-by":"publisher","first-page":"105700","DOI":"10.1016\/j.nbd.2022.105700","volume":"168","author":"F Weiss","year":"2022","unstructured":"Weiss, F., Labrador-Garrido, A., Dzamko, N. & Halliday, G. Immune responses in the Parkinson\u2019s disease brain. Neurobiol. Dis. 168, 105700 (2022).","journal-title":"Neurobiol. Dis."},{"key":"62755_CR35","doi-asserted-by":"crossref","unstructured":"Golubovskaya, V. & Wu, L. Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy. Cancers 8, 36 (2016).","DOI":"10.3390\/cancers8030036"},{"key":"62755_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(24)00140-6","volume":"23","author":"A Haghikia","year":"2024","unstructured":"Haghikia, A., Schett, G. & Mougiakakos, D. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases. Lancet Neurol. 23, 615\u2013624 (2024).","journal-title":"Lancet Neurol."},{"key":"62755_CR37","doi-asserted-by":"publisher","unstructured":"Kim, A.B. et al. Chimeric antigen receptor macrophages target and resorb amyloid plaques. JCI Insight 9, https:\/\/doi.org\/10.1172\/jci.insight.175015 (2024).","DOI":"10.1172\/jci.insight.175015"},{"key":"62755_CR38","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"62755_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"62755_CR40","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA 106, 20051\u201320056 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR41","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1073\/pnas.94.11.5744","volume":"94","author":"B Huard","year":"1997","unstructured":"Huard, B. et al. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Proc. Natl. Acad. Sci. USA 94, 5744\u20135749 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR42","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1006\/mcne.2000.0914","volume":"16","author":"C Knott","year":"2000","unstructured":"Knott, C., Stern, G. & Wilkin, G. P. Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol. Cell Neurosci. 16, 724\u2013739 (2000).","journal-title":"Mol. Cell Neurosci."},{"key":"62755_CR43","doi-asserted-by":"crossref","unstructured":"Nagatsu, T., Mogi, M., Ichinose, H. & Togari, A. Changes in cytokines and neurotrophins in Parkinson\u2019s disease. in Advances in Research on Neurodegeneration (eds Riederer, P. et al.) 277\u2013290 (Springer, 2000).","DOI":"10.1007\/978-3-7091-6301-6_19"},{"key":"62755_CR44","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1074\/jbc.RA119.012284","volume":"295","author":"J Lu","year":"2020","unstructured":"Lu, J. et al. Structural basis of the interplay between \u03b1-synuclein and Tau in regulating pathological amyloid aggregation. J. Biol. Chem. 295, 7470\u20137480 (2020).","journal-title":"J. Biol. Chem."},{"key":"62755_CR45","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"M von Bergen","year":"2000","unstructured":"von Bergen, M. et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc. Natl. Acad. Sci. USA 97, 5129\u20135134 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"62755_CR47","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1073\/pnas.97.19.10383","volume":"97","author":"B Kuhlman","year":"2000","unstructured":"Kuhlman, B. & Baker, D. Native protein sequences are close to optimal for their structures. Proc. Natl. Acad. Sci. USA 97, 10383\u201310388 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0076-6879(04)83004-0","volume":"383","author":"CA Rohl","year":"2004","unstructured":"Rohl, C. A., Strauss, C. E., Misura, K. M. & Baker, D. Protein structure prediction using Rosetta. Methods Enzymol. 383, 66\u201393 (2004).","journal-title":"Methods Enzymol."},{"key":"62755_CR49","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1021\/acs.jctc.7b00125","volume":"13","author":"RF Alford","year":"2017","unstructured":"Alford, R. F. et al. The Rosetta all-atom energy function for macromolecular modeling and design. J. Chem. Theory Comput. 13, 3031\u20133048 (2017).","journal-title":"J. Chem. Theory Comput."},{"key":"62755_CR50","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41589-023-01370-x","volume":"19","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Structural mechanism for specific binding of chemical compounds to amyloid fibrils. Nat. Chem. Biol. 19, 1235\u20131245 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"62755_CR51","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41589-024-01580-x","volume":"20","author":"RI Horne","year":"2024","unstructured":"Horne, R. I. et al. Discovery of potent inhibitors of \u03b1-synuclein aggregation using structure-based iterative learning. Nat. Chem. Biol. 20, 634\u2013645 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"62755_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217835120","volume":"120","author":"KA Murray","year":"2023","unstructured":"Murray, K. A. et al. Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils. Proc. Natl. Acad. Sci. USA 120, e2217835120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR53","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","volume":"100","author":"JL St Martin","year":"2007","unstructured":"St Martin, J. L. et al. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J. Neurochem. 100, 1449\u20131457 (2007).","journal-title":"J. Neurochem."},{"key":"62755_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41586-020-2904-6","volume":"587","author":"AS Wentink","year":"2020","unstructured":"Wentink, A. S. et al. Molecular dissection of amyloid disaggregation by human HSP70. Nature 587, 483\u2013488 (2020).","journal-title":"Nature"},{"key":"62755_CR55","doi-asserted-by":"publisher","first-page":"31190","DOI":"10.1074\/jbc.M109.057240","volume":"284","author":"SF Falsone","year":"2009","unstructured":"Falsone, S. F., Kungl, A. J., Rek, A., Cappai, R. & Zangger, K. The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein. J. Biol. Chem. 284, 31190\u201331199 (2009).","journal-title":"J. Biol. Chem."},{"key":"62755_CR56","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fnins.2019.01124","volume":"13","author":"C Jia","year":"2019","unstructured":"Jia, C. et al. Different heat shock proteins bind \u03b1-synuclein with distinct mechanisms and synergistically prevent its amyloid aggregation. Front. Neurosci. 13, 1124 (2019).","journal-title":"Front. Neurosci."},{"key":"62755_CR57","doi-asserted-by":"crossref","unstructured":"Wang, C. et al. VAMP2 chaperones \u03b1-synuclein in synaptic vesicle co-condensates. Nat. Cell Biol. 26, 1287\u20131295 (2024).","DOI":"10.1038\/s41556-024-01456-1"},{"key":"62755_CR58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","volume":"59","author":"X Gao","year":"2015","unstructured":"Gao, X. et al. Human Hsp70 disaggregase reverses Parkinson\u2019s-linked \u03b1-synuclein amyloid fibrils. Mol. Cell 59, 781\u2013793 (2015).","journal-title":"Mol. Cell"},{"key":"62755_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31787-2","volume":"13","author":"YR Butler","year":"2022","unstructured":"Butler, Y. R. et al. \u03b1-Synuclein fibril-specific nanobody reduces prion-like \u03b1-synuclein spreading in mice. Nat. Commun. 13, 4060 (2022).","journal-title":"Nat. Commun."},{"key":"62755_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf3775","volume":"9","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Single-domain antibody-based noninvasive in vivo imaging of \u03b1-synuclein or tau pathology. Sci. Adv. 9, eadf3775 (2023).","journal-title":"Sci. Adv."},{"key":"62755_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","volume":"377","author":"SM Lynch","year":"2008","unstructured":"Lynch, S. M., Zhou, C. & Messer, A. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. J. Mol. Biol. 377, 136\u2013147 (2008).","journal-title":"J. Mol. Biol."},{"key":"62755_CR62","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1111\/febs.16376","volume":"289","author":"I Hmila","year":"2022","unstructured":"Hmila, I. et al. Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity. FEBS J. 289, 4657\u20134673 (2022).","journal-title":"FEBS J."},{"key":"62755_CR63","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.jmb.2013.01.040","volume":"425","author":"T Guilliams","year":"2013","unstructured":"Guilliams, T. et al. Nanobodies raised against monomeric \u03b1-synuclein distinguish between fibrils at different maturation stages. J. Mol. Biol. 425, 2397\u20132411 (2013).","journal-title":"J. Mol. Biol."},{"key":"62755_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0390-6","volume":"15","author":"M Iljina","year":"2017","unstructured":"Iljina, M. et al. Nanobodies raised against monomeric \u0251-synuclein inhibit fibril formation and destabilize toxic oligomeric species. BMC Biol. 15, 57 (2017).","journal-title":"BMC Biol."},{"key":"62755_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11030-012-9420-z","volume":"17","author":"P Kare","year":"2013","unstructured":"Kare, P., Bhat, J. & Sobhia, M. E. Structure-based design and analysis of MAO-B inhibitors for Parkinson\u2019s disease: using in silico approaches. Mol. Divers 17, 111\u2013122 (2013).","journal-title":"Mol. Divers"},{"key":"62755_CR66","doi-asserted-by":"crossref","unstructured":"Tang, X. et al. A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation. Brief Bioinform. 25, bbae338 (2024).","DOI":"10.1093\/bib\/bbae338"},{"key":"62755_CR67","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1021\/acschemneuro.4c00086","volume":"15","author":"CAH Jones","year":"2024","unstructured":"Jones, C. A. H. et al. Computer-aided design and biological evaluation of diazaspirocyclic D(4)R antagonists. ACS Chem. Neurosci. 15, 2396\u20132407 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"62755_CR68","doi-asserted-by":"crossref","unstructured":"Andrianov, A. M., Shuldau, M. A., Furs, K. V., Yushkevich, A. M. & Tuzikov, A. V. AI-driven de novo design and molecular modeling for discovery of small-molecule compounds as potential drug candidates targeting SARS-CoV-2 main protease. Int. J. Mol. Sci. 24, 8083 (2023).","DOI":"10.3390\/ijms24098083"},{"key":"62755_CR69","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy. Cell Res 28, 897\u2013903 (2018).","journal-title":"Cell Res"},{"key":"62755_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41422-024-01022-2","volume":"35","author":"Q Xu","year":"2025","unstructured":"Xu, Q. et al. \u03b1-Synuclein amyloid fibril directly binds to LC3B and suppresses SQSTM1\/p62-mediated selective autophagy. Cell Res 35, 72\u201375 (2025).","journal-title":"Cell Res"},{"key":"62755_CR71","first-page":"35","volume":"299","author":"S Barghorn","year":"2005","unstructured":"Barghorn, S., Biernat, J. & Mandelkow, E. Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro. Methods Mol. Biol. 299, 35\u201351 (2005).","journal-title":"Methods Mol. Biol."},{"key":"62755_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26433-2","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type \u03b1-synuclein. Nat. Commun. 12, 6252 (2021).","journal-title":"Nat. Commun."},{"key":"62755_CR73","doi-asserted-by":"publisher","first-page":"20305","DOI":"10.1073\/pnas.1922741117","volume":"117","author":"K Zhao","year":"2020","unstructured":"Zhao, K. et al. Parkinson\u2019s disease-related phosphorylation at Tyr39 rearranges \u03b1-synuclein amyloid fibril structure revealed by cryo-EM. Proc. Natl. Acad. Sci. USA 117, 20305\u201320315 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR74","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"AL Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier, A. L. et al. The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc. Natl. Acad. Sci. USA 117, 4971\u20134982 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62755_CR75","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jmb.2009.05.058","volume":"390","author":"JN Rao","year":"2009","unstructured":"Rao, J. N., Kim, Y. E., Park, L. S. & Ulmer, T. S. Effect of pseudorepeat rearrangement on alpha-synuclein misfolding, vesicle binding, and micelle binding. J. Mol. Biol. 390, 516\u2013529 (2009).","journal-title":"J. Mol. Biol."},{"key":"62755_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101912","volume":"298","author":"C Huang","year":"2022","unstructured":"Huang, C. et al. The mouse nicotinamide mononucleotide adenylyltransferase chaperones diverse pathological amyloid client proteins. J. Biol. Chem. 298, 101912 (2022).","journal-title":"J. Biol. Chem."},{"key":"62755_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00197809","volume":"6","author":"F Delaglio","year":"1995","unstructured":"Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277\u2013293 (1995).","journal-title":"J. Biomol. NMR"},{"key":"62755_CR78","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/bioinformatics\/btu830","volume":"31","author":"W Lee","year":"2015","unstructured":"Lee, W., Tonelli, M. & Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 31, 1325\u20131327 (2015).","journal-title":"Bioinformatics"},{"key":"62755_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"62755_CR80","doi-asserted-by":"crossref","unstructured":"Bates, T. A. et al. Biolayer interferometry for measuring the kinetics of protein-protein interactions and nanobody binding. Nat. Protoc. 20, 861\u2013883(2024).","DOI":"10.1038\/s41596-024-01079-8"},{"key":"62755_CR81","doi-asserted-by":"publisher","first-page":"e106882","DOI":"10.1371\/journal.pone.0106882","volume":"9","author":"D Frenzel","year":"2014","unstructured":"Frenzel, D. & Willbold, D. Kinetic titration series with biolayer interferometry. PLoS ONE 9, e106882 (2014).","journal-title":"PLoS ONE"},{"key":"62755_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46898-1","volume":"15","author":"J Hu","year":"2024","unstructured":"Hu, J. et al. Phosphorylation and O-GlcNAcylation at the same \u03b1-synuclein site generate distinct fibril structures. Nat. Commun. 15, 2677 (2024).","journal-title":"Nat. Commun."},{"key":"62755_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.52601\/bpr.2022.210033","volume":"8","author":"H Long","year":"2022","unstructured":"Long, H., Zeng, S. & Li, D. Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases. Biophys. Rep. 8, 14\u201328 (2022).","journal-title":"Biophys. Rep."},{"key":"62755_CR84","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jmb.2010.11.008","volume":"405","author":"MD Tyka","year":"2011","unstructured":"Tyka, M. D. et al. Alternate states of proteins revealed by detailed energy landscape mapping. J. Mol. Biol. 405, 607\u2013618 (2011).","journal-title":"J. Mol. Biol."},{"key":"62755_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/pro.2389","volume":"23","author":"P Conway","year":"2014","unstructured":"Conway, P., Tyka, M. D., DiMaio, F., Konerding, D. E. & Baker, D. Relaxation of backbone bond geometry improves protein energy landscape modeling. Protein Sci. 23, 47\u201355 (2014).","journal-title":"Protein Sci."},{"key":"62755_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/pro.2187","volume":"22","author":"PB Stranges","year":"2013","unstructured":"Stranges, P. B. & Kuhlman, B. A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bonds. Protein Sci. 22, 74\u201382 (2013).","journal-title":"Protein Sci."},{"key":"62755_CR87","doi-asserted-by":"publisher","first-page":"e2307371120","DOI":"10.1073\/pnas.2307371120","volume":"120","author":"OJ Goudy","year":"2023","unstructured":"Goudy, O. J., Nallathambi, A., Kinjo, T., Randolph, N. Z. & Kuhlman, B. In silico evolution of autoinhibitory domains for a PD-L1 antagonist using deep learning models. Proc. Natl. Acad. Sci. USA 120, e2307371120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62755-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62755-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62755-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:08:20Z","timestamp":1768342100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62755-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62755"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62755-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the Supplementary information initially published, Supplementary Figure S1 contained an error. The single-channel images in the 3rd column (corresponding to the PFF:L3D1 = 1:1 group) were inadvertently duplicated from the 5th column (corresponding to the PFF:vRAGE = 1:1 group). The merged images for both groups were correct. The corrected Supplementary information is now available alongside the online version of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7368"}}